Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma

Br J Haematol. 2018 May;181(4):555-559. doi: 10.1111/bjh.14665. Epub 2017 Mar 24.
No abstract available

Keywords: PI3K; follicular lymphoma; idelalisib.

Publication types

  • Clinical Trial, Phase II
  • Comparative Study
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / mortality*
  • Male
  • Middle Aged
  • Purines / administration & dosage*
  • Quinazolinones / administration & dosage*
  • Recurrence
  • Survival Rate
  • United Kingdom / epidemiology

Substances

  • Purines
  • Quinazolinones
  • idelalisib